A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance

Summary

This is an open label, single site, single arm Phase II study to evaluate the combination of bicalutamide plus finasteride in men with MRI detectable significant prostate nodules followed on active surveillance.

Timeline

Start

2014-03

Primary completion

2015-03

Completion

2015-03

Outcome

Outcome not reported

Stopped (Enrollment): “Due to lack of accrual for this study. PI decided to close the study.”

Drugs

Indications